Overview

Comparative Effects of Nebivolol and Carvedilol on Diastolic Function in the Elderly Heart Failure Patients

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:
0

Participant gender:
All

Summary

Heart failure (HF) is a common and disabling condition in the elderly. Randomized clinical trials and meta-analyses have clearly demonstrated that long-term use of β blockers improves the outcomes of patients with HF. However, limited data have been available on the treatment of HF with preserved ejection fraction (EF) in the elderly. No study has specifically compared the relative effectiveness of carvedilol and nebivolol in treating HF in old age patients with preserved EF.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Dong-A University

Collaborator:

Menarini Group

Treatments:

Carvedilol
Nebivolol

Criteria

Inclusion Criteria:

- more than 70 years

- EF ≥ 40%

Exclusion Criteria:

- contraindication to the study drug